查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922978

医用血袋市场：按血液成分、产品类型、材料、技术、应用、最终用户和通路划分 - 全球预测（2026-2032年）

Medical Blood Bag Market by Blood Component, Product Type, Material, Technology, Application, End User, Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用血袋市场价值将达到 22.6 亿美元，到 2026 年将成长至 23.9 亿美元，到 2032 年将达到 32.8 亿美元，年复合成长率为 5.45%。

关键市场统计数据
基准年 2025 22.6亿美元
预计年份：2026年 23.9亿美元
预测年份 2032 32.8亿美元
复合年增长率 (%) 5.45%

简要概述影响医用血袋开发和临床应用的关键技术、监管和营运变数。

以下执行摘要概述了影响医用血袋行业的当代趋势，并为包括製造商、采购商、临床输血服务机构和研究机构在内的所有相关人员提出了关键考虑因素。它简要概述了正在重新定义产品需求、材料选择和通路的技术、监管和营运变数。本导言将帮助您了解过滤技术、材料科学和供应链管理的进步如何与不断发展的临床最佳实践相融合，从而推动产品设计和部署的重大变革。

新兴材料技术、过滤技术的进步以及供应链的数位化正在融合，重新定义血袋产业的竞争优势。

血袋产业正经历着变革性的转变，这主要得益于技术改进、材料创新以及临床需求的不断提高。整合式白血球去除过滤器技术的进步以及与添加剂溶液相容性的提升，迫使製造商重新评估血袋的结构和组装过程。同时，人们越来越倾向于选择EVA和PE等非PVC材料，这促使各机构权衡PVC的既有性能与其长期生物相容性和环境影响，从而重新评估资本投资并寻求供应商多元化。

政策主导的关税趋势正在鼓励製造商建立区域韧性、双重采购和营运效率，以保护利润和供应。

影响医疗设备原材料的关税调整和贸易政策变化，为在美国运营的製造商和采购专业人员带来了战略上的复杂性。为此，各公司正在进行有针对性的采购审查，以确定关税对聚合物树脂、特殊过滤器和组装组件等原材料到岸成本和供应商选择标准的影响。这种日益严格的关税审查促使许多企业重新评估其区域製造地，探索近岸生产方案，并加强供应商关係管理，以降低跨境成本波动的风险。

以细分市场为中心的分析揭示了组件、产品类型、材料、最终用户、通路、应用和技术等变数如何驱动差异化产品和商业化策略。

详细的细分市场分析揭示了不同维度（例如组件、产品类型、材料、最终用户、通路、应用和技术）的需求驱动因素和产品要求的差异。基于血液成分，产品开发和库存规划必须满足冷沉淀、血浆、血小板和红血球独特的稳定性、储存和处理要求，这些要求直接影响血袋设计和配件选择。基于产品类型，製造商应调整其产品组合策略，涵盖添加剂溶液袋、成分袋、辐照袋、白血球去除袋和全血袋。同时，他们必须认识到，成分袋包括专用的冷沉淀袋、血浆袋、血小板袋和红血球袋，每种袋都需要专门的密封和灭菌技术。

区域趋势导緻美洲、欧洲、中东和非洲以及亚太地区在合规性、采购和产品适应性方面有不同的优先事项。

区域市场动态凸显了不同的营运重点和法规环境，这些因素会影响产品设计、分销和伙伴关係模式。在美洲，对扩充性、遵守国家血液服务通讯协定以及与大型医院网路达成整合协议的重视，共同推动了对多功能血袋规格和强大可追溯性的需求。在欧洲、中东和非洲地区，监管碎片化和采购成熟度的差异，为模组化产品、本地化优化材料以及灵活的供应结构创造了机会，从而能够同时满足集中式血液服务和分散式医院采购的需求。

竞争差异化日益依赖材料创新、整合过滤解决方案、在地化生产和基于可追溯性的服务产品。

血袋领域的竞争优势取决于产品创新、材料采购、监管生命週期管理和通路伙伴关係等多方面的能力。主要企业正透过整合白血球去除解决方案、检验的非PVC配方以及可实现可重复无菌填充和密封的生产流程控制，投资于产品差异化。同时，建立本地灌装和包装设施以及发展分销合作伙伴关係等战略倡议，能够扩大覆盖范围并增强韧性，从而更快地响应血库和医院系统的需求，同时降低跨境中断带来的风险。

为确保供应弹性、检验材料过渡并通过区域生产能力和可追溯性，为製造商提供切实可行的优先行动，以加快临床应用。

产业领导者应优先考虑一系列切实可行的倡议，以确保供应的持续性、加速创新并提升产品生命週期内的临床相容性。首先，推进材料过渡路线图的製定，逐步验证EVA和PE等非PVC替代品的性能，检验指标包括塑化剂迁移、氧气渗透性和蓝图兼容性等，从而在保持临床性能的同时，降低长期环境和监管风险。其次，透过双重采购策略、与关键树脂和过滤介质供应商签订长期合约以及製定快速认证备用供应商的紧急时应对计画，加强供应商风险管理。

结合关键相关人员访谈、技术文献综述和供应商能力分析的综合混合方法研究途径，确保了研究结果具有可操作性。

本研究采用混合方法，整合了访谈、技术文献综述、法规指南分析和供应商环境分析，以得出可操作的见解。主要资讯收集自设备工程师、品质保证负责人、采购主管、临床输血专家和经销合作伙伴，旨在了解他们对产品性能、验证限制和采购期望的跨职能观点。此外，我们也对最新的同行评审研究、标准文件和与输液袋材料、白血球去除技术和灭菌方法相关的法规通知进行了严格的审查，以补充这些定性研究。

材料、过滤技术和供应链韧性的策略整合将决定市场领导，并提高临床环境中的输血安全性。

总而言之，医用血袋产业正处于材料创新、过滤技术进步以及受监管审查和政策转变驱动的供应链重组的交汇点。积极检验非PVC材料、投资于整合式白血球去除解决方案并推行本地化生产或填充包装策略的相关人员，将能够更好地应对成本压力、日益复杂的监管以及不断变化的临床需求。下一代血袋的成功商业化将取决于严格的兼容性测试、有针对性的临床合作以及能够满足血库、医院和研究机构多样化需求的灵活分销模式。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依血液成分分類的医用血袋市场

  • 冻结沉淀物
  • 电浆
  • 血小板
  • 红血球

第九章 依产品类型分類的医用血袋市场

  • 添加剂袋
  • 原料袋
    • 冷沉淀袋
    • 血浆袋
    • 血小板袋
    • 红血球袋
  • 辐射袋
  • 白血球去除袋
  • 全血袋

第十章 按材料分類的医用血袋市场

  • 不含聚氯乙烯
    • 伊娃
    • PE
  • PVC

第十一章 依科技分類的医用血袋市场

  • 内建白血球去除过滤器的袋子
  • 标准包

第十二章 按应用分類的医用血袋市场

  • 收藏
  • 过程
  • 贮存
  • 输血

第十三章 依终端使用者分類的医用血袋市场

  • 血库
  • 医院
  • 研究所

第十四章 医用血袋市场（依通路划分）

  • 离线
  • 在线的

第十五章 各地区医用血袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 医用血袋市场（依集团划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国医用血袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国医用血袋市场

第十九章：中国医用血袋市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advacare Pharma
  • B. Braun Melsungen AG
  • Changsha Sinch Medical Instruments Co., Ltd.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Labcaire Systems Ltd.
  • Macopharma SA
  • MEK-ICS Co., Ltd.
  • Ningbo Cland Medical Instruments Co., Ltd.
  • Poly Medicure Limited
  • Shanghai Kehua Bio-Engineering Co., Ltd.
  • Sichuan Nigale Biomedical Co., Ltd.
  • Span Healthcare Private Limited
  • Suru International Pvt. Ltd.
  • Suzhou Jinlu Medical Appliance Co., Ltd.
  • Suzhou Laishi Transfusion Equipment Co., Ltd.
  • Terumo BCT, Inc.
  • Wego Group
Product Code: MRR-867BED9A9E9A

The Medical Blood Bag Market was valued at USD 2.26 billion in 2025 and is projected to grow to USD 2.39 billion in 2026, with a CAGR of 5.45%, reaching USD 3.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.26 billion
Estimated Year [2026] USD 2.39 billion
Forecast Year [2032] USD 3.28 billion
CAGR (%) 5.45%

A concise orientation to prevailing technical, regulatory, and operational variables shaping blood bag development and clinical adoption across stakeholders

The following executive summary synthesizes contemporary dynamics shaping the medical blood bag domain and frames essential considerations for stakeholders across manufacturing, procurement, clinical transfusion services, and research institutions. It offers a concise orientation to the technical, regulatory, and operational variables that are redefining product demand, material selection, and distribution pathways. This introduction situates the reader to understand how advances in filtration, material science, and supply-chain orchestration are converging with evolving clinical best practices to produce meaningful shifts in product design and deployment.

Throughout the analysis, emphasis is placed on cross-functional impacts-from product engineering and validation cycles through to end-user adoption and logistics. Transitional realities such as heightened focus on leukoreduction efficacy and non-PVC materials are explored alongside pragmatic constraints like sterilization compatibility and cold chain demands. The goal of this section is to provide an accessible yet authoritative baseline that enables rapid comprehension of the critical vectors influencing product development priorities, regulatory preparedness, and go-to-market considerations for stakeholders aiming to optimize clinical outcomes while managing cost and supply risk.

Emerging material innovations, filtration advances, and supply chain digitization are jointly redefining competitive advantage in the blood bag ecosystem

The landscape for blood bags is undergoing transformative shifts driven by a confluence of technological refinement, material innovation, and heightened clinical expectations. Advances in integrated leukoreduction filters and improvements in additive solution compatibility are prompting manufacturers to re-evaluate bag architecture and assembly workflows. Concurrently, the rising preference for non-PVC materials such as EVA and PE is catalyzing retooling investments and supplier diversification, as organizations weigh long-term biocompatibility and environmental profiles against established PVC performance attributes.

Regulatory emphasis on transfusion safety and traceability has accelerated digital integration across the supply chain, motivating manufacturers to incorporate labeling, RFID, and data capture features into product lifecycles. These developments are reshaping competitive differentiation, with firms that successfully marry material science, filtration technology, and traceability gaining preferential positioning among progressive hospital systems and sophisticated blood banks. Furthermore, shifting procurement paradigms and channel dynamics are encouraging strategic partnerships between producers and distributors to secure resilient supply while enabling tailored clinical solutions for collection, processing, storage, and transfusion workflows.

Policy-driven tariff dynamics are driving manufacturers toward regional resilience, dual sourcing, and operational efficiencies to protect margins and supply

Tariff adjustments and trade policy changes affecting medical device inputs have introduced a layer of strategic complexity for manufacturers and procurement specialists operating in the United States. In response, firms are conducting targeted sourcing reviews to determine how duties on polymer resins, specialized filters, and assembly components influence landed costs and supplier selection criteria. This period of elevated tariff scrutiny has led many organizations to re-evaluate regional manufacturing footprints, to consider near-shore production options, and to intensify supplier relationship management as a means to mitigate exposure to cross-border cost variability.

As companies assess the implications of tariff shifts, they are increasingly prioritizing contractual flexibility and dual-sourcing strategies to preserve continuity of supply. At the same time, those with vertically integrated capabilities or established domestic production lines are leveraging these assets to secure preferred positioning with major hospital systems and blood service providers. The tariff environment has also sharpened internal focus on process efficiencies and waste reduction during component assembly and filling operations, as organizations seek to preserve margin and maintain competitive pricing without compromising regulatory compliance or clinical performance.

Segment-focused insights reveal how component, product type, material, end-user, channel, application, and technology variables drive differentiated product and commercialization strategies

Deep segmentation analysis illuminates differentiated demand drivers and product requirements across component, product type, material, end user, channel, application, and technology dimensions. Based on blood component, product development and inventory planning must accommodate the distinct stability, storage, and handling requirements of cryoprecipitate, plasma, platelets, and red blood cells, which directly inform bag formulation and accessory inclusion. Based on product type, manufacturers need to align portfolio strategies to cover additive solution bags, component bags, irradiation bags, leukocyte reduction bags, and whole blood bags, while recognizing that component bags include specialized cryoprecipitate bags, plasma bags, platelet bags, and red cell bags that each demand tailored sealing and sterile processing techniques.

Based on material, the trade-offs between PVC and non-PVC options such as EVA and PE extend beyond environmental considerations to affect oxygen permeability, plasticizer migration, and interchangeability with standardized tubing and connectors. Based on end user, the distinct procurement behaviors and clinical workflows of blood banks, hospitals, and research institutes require differentiated service, packaging, and quality documentation. Based on channel, distribution strategies must be optimized for direct sales, traditional distributors, and online fulfillment mechanisms that influence lead times and lot traceability. Based on application, the product set must service collection, processing, storage, and transfusion phases, each with specific closure integrity, bag geometry, and temperature control demands. Based on technology, portfolios should reflect the growing importance of integrated leukoreduction filter bags alongside standard bag configurations to meet clinical expectations for leukocyte removal and transfusion safety.

Regional dynamics create distinct priorities in compliance, procurement, and product adaptation across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional market dynamics underscore divergent operational priorities and regulatory environments that affect product design, distribution, and partnership models. In the Americas, emphasis is placed on scalability, compliance with national blood service protocols, and consolidation agreements with major hospital networks, which together influence demand for versatile bag formats and robust traceability features. In Europe, Middle East & Africa, regulatory fragmentation and varying procurement maturities create opportunities for modular product offerings, regionally optimized materials, and flexible supply arrangements that accommodate both centralized blood services and decentralized hospital procurement.

In Asia-Pacific, rapid healthcare expansion and investments in transfusion infrastructure are advancing adoption of advanced filtration technologies and non-PVC materials, while also placing a premium on cost-effective manufacturing and localized support models. Across all regions, manufacturers must calibrate market entry strategies to regulatory expectations for biocompatibility and sterility assurance, while tailoring commercial approaches to the distinctive procurement cycles and clinical pathways that characterize blood banks, hospitals, and research institutes in each geography.

Competitive differentiation is increasingly driven by material innovation, integrated filtration solutions, localized manufacturing, and traceability-enabled service offerings

Competitive positioning in the blood bag sector hinges on capabilities spanning product innovation, material sourcing, regulatory lifecycle management, and channel partnerships. Leading firms are investing in product differentiation through integrated leukoreduction solutions, validated non-PVC formulations, and manufacturing process controls that enable reproducible sterile filling and sealing outcomes. At the same time, strategic moves such as establishing localized fill-and-finish facilities or forging distribution alliances amplify reach and resilience, enabling faster response times to blood banks and hospital systems while reducing exposure to cross-border disruptions.

Collaboration between R&D, quality, and commercial teams is proving critical to accelerate product adoption, particularly where changes in material necessitate extensive compatibility testing with additive solutions, storage protocols, and medical devices. Companies that can effectively document clinical equivalence, secure timely regulatory clearances, and provide robust technical service are positioned to capture preference among end users. Additionally, organizations that deploy digital tools for lot traceability and post-market surveillance gain differentiation by supporting safety reporting and inventory management needs of large transfusion centers and national blood services.

Practical, prioritized actions for manufacturers to secure supply resilience, validate material transitions, and accelerate clinical adoption through regional capacity and traceability

Industry leaders should prioritize a set of actionable initiatives to safeguard supply continuity, accelerate innovation, and improve clinical alignment across the product lifecycle. First, pursue material transition roadmaps that incrementally validate non-PVC alternatives such as EVA and PE against performance criteria for plasticizer migration, oxygen permeability, and sterilization compatibility to reduce long-term environmental and regulatory risk while maintaining clinical performance. Next, enhance supplier risk management through dual-sourcing strategies, long-term agreements with critical resin and filtration suppliers, and contingency plans for rapid qualification of secondary vendors.

Further, integrate product-level traceability and data capture capabilities to support hemovigilance and inventory management for large blood banks and hospital systems. Invest in modular manufacturing and fill-and-finish capacity in target regions to shorten lead times and mitigate tariff-driven cost exposure. Strengthen cross-functional processes to accelerate compatibility testing when combining additive solutions with alternative bag materials, and establish robust clinical engagement programs that secure early adopters for new bag configurations and filtration technologies. Finally, align commercial models to support diverse channel preferences, providing differentiated support for direct institutional customers, distributor partners, and digital procurement platforms to maximize market access and responsiveness.

An integrated, mixed-methods research approach combining primary stakeholder interviews, technical literature review, and supplier capability mapping to ensure actionable insights

This research synthesis is grounded in a mixed-methods approach that integrates primary interviews, technical literature review, regulatory guidance analysis, and supplier landscape mapping to produce actionable insights. Primary inputs were gathered from device engineers, quality assurance professionals, procurement leaders, clinical transfusion specialists, and distribution partners to capture cross-functional perspectives on product performance, validation constraints, and procurement expectations. These qualitative engagements were supplemented by a rigorous review of contemporary peer-reviewed studies, standards documentation, and regulatory notices relevant to bag materials, leukoreduction technologies, and sterilization methods.

To ensure robustness, methodological triangulation was applied by cross-referencing interview findings with technical specifications, manufacturing process descriptions, and publicly available regulatory frameworks. Material compatibility assessments and technology evaluations were contextualized with documented clinical workflows for collection, processing, storage, and transfusion to reflect real-world operational priorities. The research team also applied comparative supplier profiling and capability mapping to identify strategic differentiation and potential bottlenecks across manufacturing and distribution networks, enabling recommendations that are both evidence-based and operationally actionable.

Strategic convergence of material, filtration, and supply resilience initiatives will determine market leaders and improve transfusion safety across clinical settings

In conclusion, the medical blood bag sector is at the intersection of material innovation, filtration technology advancement, and supply-chain realignment driven by regulatory scrutiny and policy shifts. Stakeholders who proactively validate non-PVC materials, invest in integrated leukoreduction solutions, and pursue regional manufacturing or fill-and-finish strategies will be better positioned to manage cost pressures, regulatory complexity, and evolving clinical expectations. The successful commercialization of next-generation bag formats will depend on rigorous compatibility testing, targeted clinical engagement, and flexible distribution models that meet the diverse needs of blood banks, hospitals, and research institutes.

Decision-makers should treat current market dynamics as an impetus for disciplined portfolio prioritization and cross-functional coordination, ensuring that R&D, quality, procurement, and commercial teams act in concert to reduce time to clinical adoption while preserving patient safety. By following an evidence-based path that balances innovation with operational resilience, organizations can secure competitive advantage and contribute to improved transfusion outcomes across geographies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Blood Bag Market, by Blood Component

  • 8.1. Cryoprecipitate
  • 8.2. Plasma
  • 8.3. Platelets
  • 8.4. Red Blood Cells

9. Medical Blood Bag Market, by Product Type

  • 9.1. Additive Solution Bags
  • 9.2. Component Bags
    • 9.2.1. Cryoprecipitate Bags
    • 9.2.2. Plasma Bags
    • 9.2.3. Platelet Bags
    • 9.2.4. Red Cell Bags
  • 9.3. Irradiation Bags
  • 9.4. Leukocyte Reduction Bags
  • 9.5. Whole Blood Bags

10. Medical Blood Bag Market, by Material

  • 10.1. Non Pvc
    • 10.1.1. Eva
    • 10.1.2. Pe
  • 10.2. Pvc

11. Medical Blood Bag Market, by Technology

  • 11.1. Integrated Leukoreduction Filter Bags
  • 11.2. Standard Bags

12. Medical Blood Bag Market, by Application

  • 12.1. Collection
  • 12.2. Processing
  • 12.3. Storage
  • 12.4. Transfusion

13. Medical Blood Bag Market, by End User

  • 13.1. Blood Banks
  • 13.2. Hospitals
  • 13.3. Research Institutes

14. Medical Blood Bag Market, by Channel

  • 14.1. Offline
  • 14.2. Online

15. Medical Blood Bag Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Blood Bag Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Blood Bag Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Medical Blood Bag Market

19. China Medical Blood Bag Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Advacare Pharma
  • 20.6. B. Braun Melsungen AG
  • 20.7. Changsha Sinch Medical Instruments Co., Ltd.
  • 20.8. Fresenius Kabi AG
  • 20.9. Fresenius SE & Co. KGaA
  • 20.10. Grifols, S.A.
  • 20.11. Haemonetics Corporation
  • 20.12. JMS Co., Ltd.
  • 20.13. Kawasumi Laboratories, Inc.
  • 20.14. Labcaire Systems Ltd.
  • 20.15. Macopharma SA
  • 20.16. MEK-ICS Co., Ltd.
  • 20.17. Ningbo Cland Medical Instruments Co., Ltd.
  • 20.18. Poly Medicure Limited
  • 20.19. Shanghai Kehua Bio-Engineering Co., Ltd.
  • 20.20. Sichuan Nigale Biomedical Co., Ltd.
  • 20.21. Span Healthcare Private Limited
  • 20.22. Suru International Pvt. Ltd.
  • 20.23. Suzhou Jinlu Medical Appliance Co., Ltd.
  • 20.24. Suzhou Laishi Transfusion Equipment Co., Ltd.
  • 20.25. Terumo BCT, Inc.
  • 20.26. Wego Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL BLOOD BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL BLOOD BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ADDITIVE SOLUTION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ADDITIVE SOLUTION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ADDITIVE SOLUTION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY IRRADIATION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY IRRADIATION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY IRRADIATION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY LEUKOCYTE REDUCTION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY LEUKOCYTE REDUCTION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY LEUKOCYTE REDUCTION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY EVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY EVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY EVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY INTEGRATED LEUKOREDUCTION FILTER BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY INTEGRATED LEUKOREDUCTION FILTER BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY INTEGRATED LEUKOREDUCTION FILTER BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STANDARD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STANDARD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STANDARD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)